Catching the therapeutic window of opportunity in early initial-onset Vogt–Koyanagi–Harada uveitis can cure the disease

• Published in: International ophthalmology Vol. 39; no. 6; pp. 1419 - 1425
• Main Authors: Herbort, Carl P., Abu El Asrar, Ahmed M., Takeuchi, Masuru, Pavésio, Carlos E., Couto, Cristobal, Hedayatfar, Alireza, Maruyama, Kazuichi, Rao, Xi, Silpa-archa, Sukhum, Somkijrungroj, Thanapong
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01.06.2019; Springer Nature B.V
• Subjects: Arthritis; Autoimmune diseases; Choroiditis; Chronic illnesses; Evolution; Immunosuppressive agents; Medical treatment; Medicine; Medicine & Public Health; Ophthalmology; Perspectives or Expert Opinions; Rheumatoid arthritis; Stroma; Uveitis; Windows (intervals); Indocyanine green angiography; Autoimmune disease; Vogt–Koyanagi–Harada disease; Immunosuppressive therapy; Therapeutic window of opportunity stromal choroiditis; Sunset glow fundus

Purpose Vogt–Koyanagi–Harada (VKH) disease is a primary autoimmune granulomatous choroiditis that begins in the choroidal stroma. The aim of this review was to gather a body of evidence for the concept of a window of therapeutic opportunity, defined as a time interval following initial-onset disease...